Active ingredientCarisbamateCat. No. P-C055-001CAS 194085-75-1Family · Pharmaceutical analytical standards
Carisbamate
A carbamate anticonvulsant, studied since the late 1990s for epileptic seizures: in 2009 it was not approved in the United States, and in 2022 it entered phase 3 trials for the epileptic disorder Lennox-Gastaut syndrome. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?The molecule originated in South Korea and is only one of the two possible mirror-image forms, the S enantiomer; it was also tested for migraine prevention, in a study of 323 patients.
Go to the active ingredient →Active ingredientCarisbamateCat. No. P-C055-001CAS 194085-75-1
Metabolite(R)-Carisbamate alpha-D-O-GlucuronideCat. No. P-C055-002
Metabolite(R)-Carisbamate beta-D-O-GlucuronideCat. No. P-C055-003CAS 940279-83-4
Metabolite(S)-Carisbamate alpha-D-O-GlucuronideCat. No. P-C055-004
Metabolite(S)-Carisbamate beta-D-O-GlucuronideCat. No. P-C055-005CAS 940279-82-3
MetaboliteCarisbamate glucuronide (mixture of diasteromers)Cat. No. P-C055-006
Isotopically labelled(R)-Carisbamate-d4Cat. No. P-C055-007CAS 1287128-99-7
Isotopically labelled(R)-Carisbamate-d4-beta-D-O-GlucuronideCat. No. P-C055-008
Isotopically labelled(S)-Carisbamate-d4Cat. No. P-C055-009CAS 1292841-50-9
Isotopically labelled(S)-Carisbamate-d4-beta-D-O-GlucuronideCat. No. P-C055-010
Isotopically labelledCarisbamate-15N-13C-d2Cat. No. P-C055-011
Isotopically labelledR-Carisbamate-15N-13C-d2Cat. No. P-C055-012
Isotopically labelledrac-Carisbamate-d4Cat. No. P-C055-013CAS 1329808-36-7
Impurity(R)-CarisbamateCat. No. P-C055-014CAS 194085-74-0
Impurity1-(2-Chlorophenyl)ethane-1,2-diolCat. No. P-C055-015CAS 59365-60-5
ImpurityCarisbamate Impurity 1Cat. No. P-C055-016CAS 52950-19-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.